Key Takeaways
  • Tirzepatide is the first dual GIP/GLP-1 agonist — a next-generation molecule after Semaglutide
  • Research Tirzepatide is no longer available from any verified supplier (delisted at CertaPeptides since mid-2026, out of stock at AuraVia Research, not available at SwissChems or AminoClub): no verified purchase option remains
  • The available and verified GLP-1 research alternative is Retatrutide — a triple GIP/GLP-1/glucagon agonist, the next generation after tirzepatide
  • Retatrutide at AuraVia Research (Europe): vial from 99 EUR (10 mg) or pre-filled pen from 199.99 EUR (15 mg), HPLC purity ≥99%, CoA for every batch, strictly for research only. AuraVia ships across Europe, including the UK, Switzerland and Norway. CertaPeptides (EU, UK, Switzerland) remains a European alternative

Our Quick Recommendation

Looking for Tirzepatide for research? Here's an important point to know: since mid-2026, research tirzepatide is no longer listed by any verified supplier (a withdrawal most likely tied to its commercialization by Eli Lilly). There is currently no verified purchase option for this molecule.

The only GLP-1 research molecule still available at our verified European supplier is Retatrutide, a triple agonist of the GIP / GLP-1 / glucagon receptors — the next generation after the dual-agonist tirzepatide.

MoleculeRegionSupplierPriceShippingAction
Retatrutide (GLP-1 alternative)Europe (incl. UK, CH, NO)AuraVia Research10 mg vial from 99 EUR, pre-filled pen from 199.99 EUR3-5 business days (EU)Order Retatrutide
RetatrutideEU, UK, SwitzerlandCertaPeptides (alternative)see site3-7 daysView at CertaPeptides
TirzepatideAll regionsNo longer available at verified suppliers (delisted mid-2026)

Important: Retatrutide is a compound strictly intended for in vitro research, not for human consumption. For other verified research peptides, see also BPC-157.

GLP-1: Semaglutide vs Tirzepatide vs RetatrutideEnglish, subtitles FR · ES · DE · IT · PT

What is Tirzepatide?

Tirzepatide is a synthetic peptide of 39 amino acids developed by Eli Lilly. It's the first dual GIP and GLP-1 receptor agonist, representing a major advancement over simple GLP-1 agonists like semaglutide.

Key Characteristics

  • Dual incretin action: Simultaneously activates GIP and GLP-1 receptors
  • Next generation: Superior efficacy to semaglutide in comparative studies (SURPASS-2)
  • Significant weight loss: Up to 20-22% body weight loss in SURMOUNT trials
  • Weekly administration: One injection per week due to its long half-life

Brand Names

Tirzepatide is marketed under two brands depending on the indication:

  • Mounjaro: For type 2 diabetes
  • Zepbound: For weight management

These pharmaceutical versions require a medical prescription. Tirzepatide as a research peptide is no longer offered by verified suppliers today. To learn more about this molecule, see our complete Tirzepatide guide.

AuraVia Research: Verified GLP-1 Alternative (Retatrutide)

AuraVia Research is a European research-peptide supplier that ships from a warehouse in the EU. Tirzepatide appears in its catalog, but it is out of stock. This verified supplier does offer Retatrutide, a triple GIP / GLP-1 / glucagon agonist, as a lyophilized vial and as a pre-filled pen.

Strengths

  • EU warehouse: standard tracked shipping in 3-5 business days within the EU
  • Shipping cost: 9 EUR, free from 150 EUR
  • Prices in EUR: VAT included
  • HPLC purity ≥99%: certificate of analysis (CoA) for every batch
  • Two formats: lyophilized vial or ready-to-use pre-filled pen, no reconstitution

Considerations

  • Ships across Europe, including the UK, Switzerland and Norway: the rates above apply to the EU; for other countries the cost is shown at checkout and import duties may apply
  • Tirzepatide and semaglutide are listed, but out of stock
  • Compound strictly intended for in vitro research

Retatrutide Available

ProductDosagePriceLink
Retatrutide (lyophilized vial)10 mg / 20 mg99 EUR / 159 EUROrder Retatrutide
Retatrutide (pre-filled pen)15 mg / 40 mg199.99 EUR / 349.99 EURView the Pre-filled Pen

The pre-filled pen is ready to use and needs no reconstitution. Our retatrutide pen article covers it in detail, and our vial or pre-filled pen guide compares the two formats.

Alternative: CertaPeptides (EU, UK, Switzerland)

CertaPeptides, a supplier based in Romania, no longer offers tirzepatide since mid-2026 but still sells Retatrutide and ships to the EU, the UK and Switzerland: it is a European alternative to AuraVia Research. Shipping in 3-7 business days, HPLC tests >=98%, independent certificate of analysis (Janoshik/Finnrick), credit card and crypto accepted, returns limited to 14 days. For other GLP-1 research compounds, browse its GLP-1 category.

Verified GLP-1 alternative: since research tirzepatide is no longer available, Retatrutide is the reliable GLP-1 option at AuraVia Research in Europe, as a vial or a pre-filled pen.

View Retatrutide at AuraVia Research

Why is Tirzepatide No Longer Available?

Unlike established peptides like BPC-157 or TB-500, research Tirzepatide has been fully delisted at verified suppliers mid-2026. Several factors explain this withdrawal:

1. Likely Regulatory Withdrawal

Since tirzepatide is now a molecule widely commercialized by Eli Lilly (Mounjaro, Zepbound), its availability as a research peptide was pulled from the catalogs of verified suppliers mid-2026. The old product URLs now redirect to the category page.

2. Synthesis Complexity

Tirzepatide is a 39 amino acid peptide with an acylation modification (C20 fatty acid chain). This complex structure makes its synthesis difficult and expensive.

3. Active Patents and Pharmaceutical Demand

Eli Lilly holds patents on Tirzepatide, and global demand for Mounjaro and Zepbound is enormous (over $10 billion in annual sales), which limits research supply.

Tirzepatide Status at Verified Suppliers

SupplierTirzepatide StatusAvailable GLP-1 Research Molecule
AuraVia ResearchListed, out of stockRetatrutide (vial and pre-filled pen)
CertaPeptidesDelisted (mid-2026)Retatrutide (European alternative)
SwissChemsNot availableNo verified GLP-1 research molecule
AminoClubNot availableGHK-Cu (non-GLP-1)

Since research tirzepatide is no longer available at any verified source, Retatrutide (triple GIP/GLP-1/glucagon agonist) is the available and verified GLP-1 research alternative at AuraVia Research in Europe, as a vial or a pre-filled pen.

How to Verify the Quality of a GLP-1 Research Peptide

Whether it's tirzepatide (now unavailable) or its alternative retatrutide, it's crucial to verify quality before purchasing. Here are the essential criteria:

1. Certificate of Analysis (CoA)

A valid CoA must include:

  • HPLC chromatogram: Purity >=98%
  • Mass spectrometry (MS): Confirmation of molecular weight
  • Amino acid sequence: Verification of the full sequence
  • Batch number: Matching the received product

For reference, tirzepatide is a 39 amino acid peptide with a molecular weight of 4813.45 g/mol.

2. Realistic Pricing

GLP-1 peptides are expensive to produce. A price that's "too good to be true" is a major red flag. At AuraVia Research, verified Retatrutide is offered at 99 EUR for a 10 mg vial; be wary of abnormally low prices or unverified sources.

3. Storage and Shipping

These peptides are temperature sensitive. Verify:

  • Storage at -20C before shipping
  • Shipping with ice packs
  • Insulated packaging

4. Supplier Reputation

Look for independent reviews on Reddit, specialized forums, and check the supplier's track record.

Our verified GLP-1 research alternative:

Tirzepatide Buying FAQ

Frequently Asked Questions

Can you still buy research Tirzepatide?
No. Since mid-2026, research tirzepatide is no longer available from verified suppliers (delisted at CertaPeptides, not available at SwissChems or AminoClub, out of stock at AuraVia Research), most likely due to its status as a commercialized molecule. There is currently no verified purchase option. The only GLP-1 research molecule still available from a verified source is Retatrutide, offered by AuraVia Research (vial and pre-filled pen), which ships across Europe including the UK, Switzerland and Norway, with CertaPeptides (EU, UK, Switzerland) as a European alternative. Research peptides are not intended for human consumption.
What's the difference between research Tirzepatide and Mounjaro?
The active ingredient is identical. Mounjaro/Zepbound are approved medications, manufactured according to pharmaceutical GMP standards, with guaranteed dosing and available by prescription. Tirzepatide as a research peptide is intended for in vitro studies; however, it is no longer offered by verified suppliers since mid-2026.
What is Retatrutide and why is it offered as an alternative?
Retatrutide is a triple agonist of the GIP, GLP-1 and glucagon receptors, often described as the next generation after the dual-agonist tirzepatide. It's the only GLP-1 research peptide still available from a verified supplier (AuraVia Research, EU), as a vial from 99 EUR (10 mg) or a pre-filled pen from 199.99 EUR (15 mg), with HPLC purity ≥99% and a CoA for every batch. Like all research peptides, it is strictly for in vitro research only and not intended for human consumption.
Can I buy Tirzepatide in the USA?
No. No verified supplier offers Tirzepatide for research, in the USA or elsewhere, since its delisting mid-2026. Retatrutide, the GLP-1 research alternative, is available from AuraVia Research, which ships across Europe (including the UK, Switzerland and Norway), and from CertaPeptides (EU, UK, Switzerland): neither ships to the USA.
How should I store Tirzepatide after receiving it?
Lyophilized (powder) form: store in freezer at -20C, protected from light. Shelf life: up to 2 years. After reconstitution: refrigerator (2-8C), use within 2-4 weeks. These same storage principles apply to GLP-1 research peptides like retatrutide.
Is Tirzepatide more effective than Semaglutide?
Clinical studies (SURPASS-2) suggest superior efficacy of Tirzepatide for weight loss (20-22% vs 15-17%) and glycemic control. However, these comparisons concern approved pharmaceutical versions. For research purposes, see our Tirzepatide guide for more details.
Is there a CertaPeptides discount code?
Yes. Our partner code AFF-KLOWPEPTIDE gives 10% off your first order at CertaPeptides. It is not applied automatically: enter it in the coupon field of your cart. When you click a CertaPeptides link on our site, the code is copied for you.
Does AuraVia Research have a discount code?
You do not need a code. Through our links, AuraVia Research gives 10% off your first order: the discount is applied automatically in the cart.

Recommended products

Research peptides selected for quality and purity:

Pen · Europe
Retatrutide Pen

Retatrutide Pen

Pre-filled Pen Retatrutide

Pack · Europe
Transform DUO

Transform DUO

2-pen pack: Retatrutide, Glow

New
Retatrutide

Retatrutide

Metabolic Peptide

US only
Tirzepatide

Tirzepatide

Metabolic Peptide

Test your knowledge

Quick quiz · 6 questions

Sources

  1. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. (PubMed)
  2. Frias JP, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine. (PubMed)
  3. Nauck MA, D'Alessio DA (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology. (PubMed)

This content is for informational and educational purposes only. It does not constitute medical advice. Consult a healthcare professional before making any decisions. Read our full medical disclaimer